96 related articles for article (PubMed ID: 27685907)
1. Cbl-b regulates the sensitivity of cetuximab through ubiquitin-proteasome system in human gastric cancer cells.
Yu P; Fan Y; Qu X; Zhang J; Song N; Liu J; Liu Y
J BUON; 2016; 21(4):867-873. PubMed ID: 27685907
[TBL] [Abstract][Full Text] [Related]
2. Cbl-b-dependent degradation of FLIP(L) is involved in ATO-induced autophagy in leukemic K562 and gastric cancer cells.
Zhang G; Liu J; Zhang Y; Qu J; Xu L; Zheng H; Liu Y; Qu X
FEBS Lett; 2012 Sep; 586(19):3104-10. PubMed ID: 22884570
[TBL] [Abstract][Full Text] [Related]
3. E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells.
Xu L; Zhang Y; Qu X; Che X; Guo T; Cai Y; Li A; Li D; Li C; Wen T; Fan Y; Hou K; Ma Y; Hu X; Liu Y
Neoplasia; 2017 Apr; 19(4):374-382. PubMed ID: 28334634
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-Cbl, Cbl-b, and epidermal growth factor receptor in gastric carcinoma and their clinical significance.
Dong Q; Liu YP; Qu XJ; Hou KZ; Li LL
Chin J Cancer; 2010 Jan; 29(1):59-64. PubMed ID: 20038312
[TBL] [Abstract][Full Text] [Related]
5. TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells.
Xu L; Zhang Y; Liu J; Qu J; Hu X; Zhang F; Zheng H; Qu X; Liu Y
Eur J Cancer; 2012 Nov; 48(17):3288-99. PubMed ID: 22456178
[TBL] [Abstract][Full Text] [Related]
6. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.
Xu L; Zhang Y; Qu X; Che X; Guo T; Li C; Ma R; Fan Y; Ma Y; Hou K; Li D; Hu X; Liu B; Yu R; Yan H; Gong J; Liu Y
Mol Oncol; 2017 Dec; 11(12):1733-1751. PubMed ID: 28972304
[TBL] [Abstract][Full Text] [Related]
7. Cetuximab-induced insulin-like growth factor receptor I activation mediates cetuximab resistance in gastric cancer cells.
Li X; Xu L; Li H; Zhao L; Luo Y; Zhu Z; Liu Y; Qu X
Mol Med Rep; 2015 Jun; 11(6):4547-54. PubMed ID: 25625229
[TBL] [Abstract][Full Text] [Related]
8. The role of cbl family of ubiquitin ligases in gastric cancer exosome-induced apoptosis of Jurkat T cells.
Qu JL; Qu XJ; Qu JL; Qu XJ; Zhao MF; Teng YE; Zhang Y; Hou KZ; Jiang YH; Yang XH; Liu YP
Acta Oncol; 2009; 48(8):1173-80. PubMed ID: 19863226
[TBL] [Abstract][Full Text] [Related]
9. Cbl-b enhances sensitivity to 5-fluorouracil via EGFR- and mitochondria-mediated pathways in gastric cancer cells.
Feng D; Ma Y; Liu J; Xu L; Zhang Y; Qu J; Liu Y; Qu X
Int J Mol Sci; 2013 Dec; 14(12):24399-411. PubMed ID: 24351824
[TBL] [Abstract][Full Text] [Related]
10. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
Harding J; Burtness B
Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
[TBL] [Abstract][Full Text] [Related]
11. PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells.
Li D; Qu X; Hou K; Zhang Y; Dong Q; Teng Y; Zhang J; Liu Y
Anticancer Drugs; 2009 Jan; 20(1):59-64. PubMed ID: 19343001
[TBL] [Abstract][Full Text] [Related]
12. The E3 ubiquitin ligase Cbl-b inhibits tumor growth in multidrug-resistant gastric and breast cancer cells.
CHe X; Zhang Y; Qu X; Guo T; Ma Y; Li C; Fan Y; Hou K; Cai Y; Yu R; Zhou H; He X; Wu H; Liu Y; Xu L
Neoplasma; 2017; 64(6):887-892. PubMed ID: 28895413
[TBL] [Abstract][Full Text] [Related]
13. Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells.
Zhang Y; Qu X; Hu X; Yang X; Hou K; Teng Y; Zhang J; Sada K; Liu Y
J Pathol; 2009 Jun; 218(2):248-55. PubMed ID: 19274672
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway.
Cao Y; Qu J; Li C; Yang D; Hou K; Zheng H; Liu Y; Qu X
Tumour Biol; 2015 Jul; 36(7):5607-15. PubMed ID: 25701378
[TBL] [Abstract][Full Text] [Related]
15. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
Ahmad G; Mohapatra BC; Schulte NA; Nadeau SA; Luan H; Zutshi N; Tom E; Ortega-Cava C; Tu C; Sanada M; Ogawa S; Toews ML; Band V; Band H
Int J Biochem Cell Biol; 2014 Dec; 57():123-34. PubMed ID: 25449262
[TBL] [Abstract][Full Text] [Related]
16. Association of amphiregulin with the cetuximab sensitivity of gastric cancer cell lines.
Kneissl J; Keller S; Lorber T; Heindl S; Keller G; Drexler I; Hapfelmeier A; Höfler H; Luber B
Int J Oncol; 2012 Aug; 41(2):733-44. PubMed ID: 22614881
[TBL] [Abstract][Full Text] [Related]
17. Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibody.
Lee JM; Kim B; Lee SB; Jeong Y; Oh YM; Song YJ; Jung S; Choi J; Lee S; Cheong KH; Kim DU; Park HW; Han YK; Kim GW; Choi H; Song PH; Kim KA
Oncogene; 2014 Jan; 33(1):34-43. PubMed ID: 23208509
[TBL] [Abstract][Full Text] [Related]
18. Lipid raft-regulated IGF-1R activation antagonizes TRAIL-induced apoptosis in gastric cancer cells.
Xu L; Qu X; Hu X; Zhu Z; Li C; Li E; Ma Y; Song N; Liu Y
FEBS Lett; 2013 Nov; 587(23):3815-23. PubMed ID: 24161672
[TBL] [Abstract][Full Text] [Related]
19. The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis.
Zhang L; Teng Y; Fan Y; Wang Y; Li W; Shi J; Ma Y; Li C; Shi X; Qu X; Liu Y
Oncotarget; 2015 Sep; 6(26):22918-33. PubMed ID: 26087197
[TBL] [Abstract][Full Text] [Related]
20. Role of epidermal growth factor receptor degradation in cisplatin-induced cytotoxicity in head and neck cancer.
Ahsan A; Hiniker SM; Ramanand SG; Nyati S; Hegde A; Helman A; Menawat R; Bhojani MS; Lawrence TS; Nyati MK
Cancer Res; 2010 Apr; 70(7):2862-9. PubMed ID: 20215522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]